Literature DB >> 3618534

Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis.

R M Francis, M Peacock.   

Abstract

To investigate whether low calcium absorption in osteoporosis improves by increasing 1,25-dihydroxyvitamin D both systemically in plasma and locally in gut, the effects of oral 25-hydroxycholecalciferol and oral 1,25-dihydroxycholecalciferol on plasma 1,25-dihydroxy-vitamin D (1,25-(OH)2D) and calcium absorption were studied in 20 postmenopausal patients with vertebral osteoporosis. In 10 patients taking oral 0.25 micrograms 1,25-dihydroxycholecalciferol twice daily for 7 d, calcium absorption increased more than in 10 patients taking oral 40 micrograms 25-hydroxycholecalciferol once daily for 7 d (p less than 0.02) despite both groups having a similar increase in plasma 1,25-(OH)2D. These results support the view that the major effects of oral 1,25-dihydroxycholecalciferol on absorption is due to a local action on the gut and that it is possible to increase calcium absorption in osteoporosis with oral 1,25-dihydroxycholecalciferol without increasing its undesirable action on bone resorption.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3618534     DOI: 10.1093/ajcn/46.2.315

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

1.  A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures.

Authors:  R M Francis; I T Boyle; C Moniz; A M Sutcliffe; B S Davis; G H Beastall; R A Cowan; N Downes
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 2.  Is there a role for vitamin D in osteoporosis?

Authors:  C Lamberg-Allardt
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

3.  Calcium absorption in normal and osteoporotic postmenopausal women.

Authors:  H A Morris; A G Need; M Horowitz; P D O'Loughlin; B E Nordin
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

4.  Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.

Authors:  S A Brown; D A Ontjes; G E Lester; R K Lark; M B Hensler; A D Blackwood; M J Caminiti; D C Backlund; R M Aris
Journal:  Osteoporos Int       Date:  2003-05-28       Impact factor: 4.507

5.  Decrease in bone level of 1,25-dihydroxyvitamin D in women over 45 years old.

Authors:  P Sagiv; C Lidor; T Hallel; S Edelstein
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

Review 6.  Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

Review 7.  Calcium absorption in man: some dosing recommendations.

Authors:  J Blanchard; J M Aeschlimann
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

Review 8.  Vitamin D interactions with soy isoflavones on bone after menopause: a review.

Authors:  Clara Y Park; Connie M Weaver
Journal:  Nutrients       Date:  2012-11-06       Impact factor: 5.717

9.  Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.

Authors:  T Masud; B Mulcahy; A V Thompson; S Donnelly; R W Keen; D V Doyle; T D Spector
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.